These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12085975)

  • 21. AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats.
    Walther T; Siems WE; Hauke D; Spillmann F; Dendorfer A; Krause W; Schultheiss HP; Tschöpe C
    FASEB J; 2002 Aug; 16(10):1237-41. PubMed ID: 12153991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety profile of quinapril: is there a difference among ACE inhibitors?
    Canter D; Frank GJ; Knapp LE; McLain RW
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII39-42. PubMed ID: 2189620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
    Kromer EP; Elsner D; Riegger GA
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):9-14. PubMed ID: 1696671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.
    Brower GL; Levick SP; Janicki JS
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3057-64. PubMed ID: 17308006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat.
    Sia YT; Lapointe N; Parker TG; Tsoporis JN; Deschepper CF; Calderone A; Pourdjabbar A; Jasmin JF; Sarrazin JF; Liu P; Adam A; Butany J; Rouleau JL
    Circulation; 2002 May; 105(21):2549-55. PubMed ID: 12034664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling.
    Nong Z; Stassen JM; Moons L; Collen D; Janssens S
    Circulation; 1996 Oct; 94(8):1941-7. PubMed ID: 8873672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
    Riegger GA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart failure development in rats with ascending aortic constriction and angiotensin-converting enzyme inhibition.
    Turcani M; Rupp H
    Br J Pharmacol; 2000 Aug; 130(7):1671-7. PubMed ID: 10928973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril.
    Ma M; Watanabe K; Wahed MI; Inoue M; Sekiguchi T; Kouda T; Ohta Y; Nakazawa M; Yoshida Y; Yamamoto T; Hanawa H; Kodama M; Fuse K; Aizawa Y
    J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S51-4. PubMed ID: 11811359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat.
    Lapointe N; Blais C; Adam A; Parker T; Sirois MG; Gosselin H; Clément R; Rouleau JL
    J Am Coll Cardiol; 2002 May; 39(10):1692-8. PubMed ID: 12020499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
    Culy CR; Jarvis B
    Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.
    Seeland U; Kouchi I; Zolk O; Jockenhövel F; Itter G; Linz W; Böhm M
    Eur J Heart Fail; 2003 Jun; 5(3):241-6. PubMed ID: 12798820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of quinapril initiated during progressive remodeling in asymptomatic patients with healed myocardial infarction.
    Gaudron P; Kugler L; Hu K; Fraccarollo D; Bauer W; Eilles C; Ertl G
    Am J Cardiol; 2000 Jul; 86(2):139-44. PubMed ID: 10913472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats.
    Ruzicka M; Skarda V; Leenen FH
    Circulation; 1995 Dec; 92(12):3568-73. PubMed ID: 8521580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of EDHF by chronic ACE inhibition declines rapidly after withdrawal in rats with myocardial infarction.
    Westendorp B; Schoemaker RG; van Gilst WH; Buikema H
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):766-72. PubMed ID: 16306800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
    Jondeau G; Dib JC; Dubourg O; Bourdarias JP
    Am J Cardiol; 1997 Mar; 79(5):635-8. PubMed ID: 9068523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation.
    Maki T; Nasa Y; Tanonaka K; Takahashi M; Takeo S
    J Pharmacol Exp Ther; 2003 Apr; 305(1):97-105. PubMed ID: 12649357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.